CoChat

Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages

Open access

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Abstract

Supercentenarians (those aged ≥110 years) are approaching the current human longevity limit by preventing or surviving major illness. Identifying specific biomarkers conducive to exceptional survival might provide insights into counter-regulatory mechanisms against aging-related disease. Here, we report associations between cardiovascular disease-related biomarkers and survival to the highest ages using a unique dataset of 1,427 oldest individuals from three longitudinal cohort studies, including 36 supercentenarians, 572 semi-supercentenarians (105-109 years), 288 centenarians (100-104 years), and 531 very old people (85-99 years). During follow-up, 1,000 participants (70.1%) died. Overall, N-terminal pro-B-type natriuretic peptide (NT-proBNP), interleukin-6, cystatin C and cholinesterase are associated with all-cause mortality independent of traditional cardiovascular risk factors and plasma albumin. Of these, low NT-proBNP levels are statistically associated with a survival advantage to supercentenarian age. Only low albumin is associated with high mortality across age groups. These findings expand our knowledge on the biology of human longevity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-17636-0

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Plasma extracellular superoxide dismutase concentrations by SOD3 R213G variant (rs1799895). Plasma concentrations of extracellular superoxide dismutase (EC-SOD) were measured in R213G non-carriers (RR, N = 1014), R213G heterozygotes (RG, N = 95), and R213G homozygotes (GG, N = 7). As compared to non-carriers, EC-SOD concentrations were significantly higher in heterozygotes or homozygotes (P < 1E−15, P = 1.1295E−4, respectively), Violin plots show plasma concentrations of EC-SOD by SOD3 R213G variants. Boxes denote interquartile range, the horizontal lines denote medians, and whiskers denote 10th (lower) and 90th (upper) percentiles. P values are from one-way ANOVA with post hoc Bonferroni test.
Fig. 1 Plasma extracellular superoxide dismutase concentrations by SOD3 R213G variant (rs1799895). Plasma concentrations of extracellular superoxide dismutase (EC-SOD) were measured in R213G non-carriers (RR, N = 1014), R213G heterozygotes (RG, N = 95), and R213G homozygotes (GG, N = 7). As compared to non-carriers, EC-SOD concentrations were significantly higher in heterozygotes or homozygotes (P < 1E−15, P = 1.1295E−4, respectively), Violin plots show plasma concentrations of EC-SOD by SOD3 R213G variants. Boxes denote interquartile range, the horizontal lines denote medians, and whiskers denote 10th (lower) and 90th (upper) percentiles. P values are from one-way ANOVA with post hoc Bonferroni test.CC BY · PubMed Central
Fig. 2 Cross-sectional associations between circulating biomarkers and age by cardiovascular status. Scatter plots show cross-sectional associations between biomarkers of cardioprotective pathways (a–d), inflammation (e–g), organ reserve (h, i), and selected traditional risk factors (j–l) and age at enrollment, according to presence (red) or absence (blue) of a cardiovascular abnormality. All the biomarkers were assessed at the time of enrollment. Spearman’s correlation coefficients between biomarkers and age at enrollment and sample numbers are shown for those with (red) or without (blue) cardiovascular abnormality. The solid lines represent the correlation lines, and the shaded area represents the 95% confidence interval of the correlation line. Unrelated family members of the centenarians (spouses of the first-degree offspring of the centenarians) aged between 48 and 94 years (mean age, 73.1 years) were included as a younger control group (n = 167 at the maximum). Characteristics of this population are described in ref. 31. Population sizes for the twelve biomarkers differ due to variation in the bio-banking of samples. Participants were considered to have a cardiovascular abnormality when one or more of the following criteria were fulfilled: (1) a history of coronary heart disease or stroke, (2) cardiovascular medication use (i.e., nitrate, oral anticoagulant, antiarrhythmic drug, or digoxin), and (3) a major electrocardiographic abnormality (Table 1 and Supplementary Table 1). Classification of cardiovascular abnormality in unrelated family of centenarians was based on medical history and medication list because of lack of ECG assessment in this population. NT-proBNP indicates N-terminal pro-brain natriuretic peptide, EC-SOD extracellular superoxide dismutase, TNF-alpha tumor necrosis factor-alpha, Angptl2 angiopoietin-like protein 2. a Only individuals with 213RR genotype (non-carrier) in SOD3 (rs1799895) were included in the analysis. *P < 0.001.
Fig. 2 Cross-sectional associations between circulating biomarkers and age by cardiovascular status. Scatter plots show cross-sectional associations between biomarkers of cardioprotective pathways (a–d), inflammation (e–g), organ reserve (h, i), and selected traditional risk factors (j–l) and age at enrollment, according to presence (red) or absence (blue) of a cardiovascular abnormality. All the biomarkers were assessed at the time of enrollment. Spearman’s correlation coefficients between biomarkers and age at enrollment and sample numbers are shown for those with (red) or without (blue) cardiovascular abnormality. The solid lines represent the correlation lines, and the shaded area represents the 95% confidence interval of the correlation line. Unrelated family members of the centenarians (spouses of the first-degree offspring of the centenarians) aged between 48 and 94 years (mean age, 73.1 years) were included as a younger control group (n = 167 at the maximum). Characteristics of this population are described in ref. 31. Population sizes for the twelve biomarkers differ due to variation in the bio-banking of samples. Participants were considered to have a cardiovascular abnormality when one or more of the following criteria were fulfilled: (1) a history of coronary heart disease or stroke, (2) cardiovascular medication use (i.e., nitrate, oral anticoagulant, antiarrhythmic drug, or digoxin), and (3) a major electrocardiographic abnormality (Table 1 and Supplementary Table 1). Classification of cardiovascular abnormality in unrelated family of centenarians was based on medical history and medication list because of lack of ECG assessment in this population. NT-proBNP indicates N-terminal pro-brain natriuretic peptide, EC-SOD extracellular superoxide dismutase, TNF-alpha tumor necrosis factor-alpha, Angptl2 angiopoietin-like protein 2. a Only individuals with 213RR genotype (non-carrier) in SOD3 (rs1799895) were included in the analysis. *P < 0.001.CC BY · PubMed Central
Fig. 3 Flowchart of statistical analysis to identify specific biomarkers associated with exceptional survival. NT-proBNP N-terminal pro-brain natriuretic peptide, EC-SOD extracellular superoxide dismutase, TNF-alpha tumor necrosis factor-alpha, Angptl2 angiopoietin-like protein 2.
Fig. 3 Flowchart of statistical analysis to identify specific biomarkers associated with exceptional survival. NT-proBNP N-terminal pro-brain natriuretic peptide, EC-SOD extracellular superoxide dismutase, TNF-alpha tumor necrosis factor-alpha, Angptl2 angiopoietin-like protein 2.CC BY · PubMed Central
Fig. 4 Hazard ratios for death from all causes according to candidate biomarkers. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated with the use of univariate and multivariate Cox proportional hazard models for the entire cohort, those aged 85–99 years at enrollment, 100–104 years at enrollment, and 105 years or older at enrollment. Because the number of individuals aged 110 years or older was too small for multiple analyses, this age group was included in the group over 105 years old. Multivariate analyses were adjusted for the base model covariates; sex, age, educational status, current smoking, history of cardiovascular disease, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease (stage 3b-5), CRP (≥0.3 mg/dL), major ECG abnormality, cardiovascular medications, and low plasma albumin (<3.5 g/dL). Each biomarker was entered independently into the models and hazard ratios for each biomarker are reported per 1 SD increment in natural log-transformed values except cystatin C and cholinesterase. For associations of interleukin-6 with mortality, CRP ( ≥0.3 mg/dL) was excluded from the base model because it is a downstream biomarker of the interleukin-6 pathway72. a For associations between EC-SOD and mortality, only individuals with 213RR genotype (non-carrier) in SOD3 (rs1799895) were included in the analysis. A forest plot shows multivariate-adjusted hazard ratio (squares) and 95% confidence interval (horizontal lines). Two-sided P values were calculated from Cox proportional hazard models. NT-proBNP N-terminal pro-brain natriuretic peptide, EC-SOD extracellular superoxide dismutase, TNF-alpha tumor necrosis factor-alpha, Angptl2 angiopoietin-like protein 2.
Fig. 4 Hazard ratios for death from all causes according to candidate biomarkers. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated with the use of univariate and multivariate Cox proportional hazard models for the entire cohort, those aged 85–99 years at enrollment, 100–104 years at enrollment, and 105 years or older at enrollment. Because the number of individuals aged 110 years or older was too small for multiple analyses, this age group was included in the group over 105 years old. Multivariate analyses were adjusted for the base model covariates; sex, age, educational status, current smoking, history of cardiovascular disease, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease (stage 3b-5), CRP (≥0.3 mg/dL), major ECG abnormality, cardiovascular medications, and low plasma albumin (<3.5 g/dL). Each biomarker was entered independently into the models and hazard ratios for each biomarker are reported per 1 SD increment in natural log-transformed values except cystatin C and cholinesterase. For associations of interleukin-6 with mortality, CRP ( ≥0.3 mg/dL) was excluded from the base model because it is a downstream biomarker of the interleukin-6 pathway72. a For associations between EC-SOD and mortality, only individuals with 213RR genotype (non-carrier) in SOD3 (rs1799895) were included in the analysis. A forest plot shows multivariate-adjusted hazard ratio (squares) and 95% confidence interval (horizontal lines). Two-sided P values were calculated from Cox proportional hazard models. NT-proBNP N-terminal pro-brain natriuretic peptide, EC-SOD extracellular superoxide dismutase, TNF-alpha tumor necrosis factor-alpha, Angptl2 angiopoietin-like protein 2.CC BY · PubMed Central
Fig. 5 Hazard ratios for death from any causes according to traditional cardiovascular risk factors and albumin. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated with the use of univariate and multivariate Cox proportional hazard models for the entire cohort, those aged 85–99 years at enrollment, 100–104 years at enrollment, and 105 years or older at enrollment. Because the number of individuals aged 110 years or older was too small for multiple analyses, this age group was included in the group over 105 years old. Multivariate analyses were adjusted for the base model covariates; sex, age, educational status, current smoking, history of cardiovascular disease, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease (stage 3b-5), CRP ( ≥0.3 mg/dL), major ECG abnormality, cardiovascular medications, and low plasma albumin (<3.5 g/dL). Each risk factor (continuous variable) was entered independently into the models and hazard ratios for each risk factor are reported per 1 SD increment except CRP (1 SD increment in natural log-transformed values for CRP). Hyperlipidemia was excluded from the base model for associations of HDL or LDL cholesterol levels with mortality, and diabetes mellitus was excluded for association of hemoglobin A1c with mortality. A forest plot shows multivariate-adjusted hazard ratio (squares) and 95% confidence interval (horizontal lines). Two-sided P values were calculated from Cox proportional hazard models. aeGFR-cr, CRP and albumin were entered into the base model as continuous variables instead of categorical variables. HDL indicates high-density lipoprotein, LDL low-density lipoprotein, eGFR-cr estimated glomerular filtration rate based on plasma creatinine.
Fig. 5 Hazard ratios for death from any causes according to traditional cardiovascular risk factors and albumin. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated with the use of univariate and multivariate Cox proportional hazard models for the entire cohort, those aged 85–99 years at enrollment, 100–104 years at enrollment, and 105 years or older at enrollment. Because the number of individuals aged 110 years or older was too small for multiple analyses, this age group was included in the group over 105 years old. Multivariate analyses were adjusted for the base model covariates; sex, age, educational status, current smoking, history of cardiovascular disease, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease (stage 3b-5), CRP ( ≥0.3 mg/dL), major ECG abnormality, cardiovascular medications, and low plasma albumin (<3.5 g/dL). Each risk factor (continuous variable) was entered independently into the models and hazard ratios for each risk factor are reported per 1 SD increment except CRP (1 SD increment in natural log-transformed values for CRP). Hyperlipidemia was excluded from the base model for associations of HDL or LDL cholesterol levels with mortality, and diabetes mellitus was excluded for association of hemoglobin A1c with mortality. A forest plot shows multivariate-adjusted hazard ratio (squares) and 95% confidence interval (horizontal lines). Two-sided P values were calculated from Cox proportional hazard models. aeGFR-cr, CRP and albumin were entered into the base model as continuous variables instead of categorical variables. HDL indicates high-density lipoprotein, LDL low-density lipoprotein, eGFR-cr estimated glomerular filtration rate based on plasma creatinine.CC BY · PubMed Central
Fig. 6 Selected best set of prognostic markers by LASSO-Cox regression analysis. The least absolute shrinkage and selection operator (LASSO) coefficient profiles of 17 markers associated with mortality were generated for the entire cohort (a), those aged 85–99 years at enrollment (b), 100–104 years at enrollment (c), and 105 years or older at enrollment (d). Vertical lines were drawn at the optimal values by using five-fold cross-validation. Lasso coefficients of 17 markers are shown in Supplementary Table 6. e Multivariate Cox regression models were performed to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for LASSO-selected markers (e). To identify the best overall set of prognostic markers, the prognostic biomarkers identified in Fig. 4 (NT-proBNP, interleukin-6, cystatin C, and cholinesterase) and Fig. 5 (creatinine, CRP, and albumin) were combined with clinical covariates in the base model; sex, age, educational status, current smoking, history of cardiovascular disease, hypertension, hyperlipidemia, diabetes mellitus, major ECG abnormality, and cardiovascular medications. To standardize the number of participants for the multiple biomarker-risk factor comparisons, we restricted analyses to participants with complete data on all biomarkers. A forest plot shows multivariate-adjusted hazard ratio (squares) and 95% confidence interval (horizontal lines). NT-proBNP indicates N-terminal pro-brain natriuretic peptide, IL-6 interleukin-6, Cyst C cystatin C, ChE cholinesterase, CRP C-reactive protein, Alb albumin, Edu educational status, CVD cardiovascular disease, HBP high blood pressure, HL hyperlipidemia, Major ECG major electrocardiographic abnormality, CV drug cardiovascular medication.
Fig. 6 Selected best set of prognostic markers by LASSO-Cox regression analysis. The least absolute shrinkage and selection operator (LASSO) coefficient profiles of 17 markers associated with mortality were generated for the entire cohort (a), those aged 85–99 years at enrollment (b), 100–104 years at enrollment (c), and 105 years or older at enrollment (d). Vertical lines were drawn at the optimal values by using five-fold cross-validation. Lasso coefficients of 17 markers are shown in Supplementary Table 6. e Multivariate Cox regression models were performed to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for LASSO-selected markers (e). To identify the best overall set of prognostic markers, the prognostic biomarkers identified in Fig. 4 (NT-proBNP, interleukin-6, cystatin C, and cholinesterase) and Fig. 5 (creatinine, CRP, and albumin) were combined with clinical covariates in the base model; sex, age, educational status, current smoking, history of cardiovascular disease, hypertension, hyperlipidemia, diabetes mellitus, major ECG abnormality, and cardiovascular medications. To standardize the number of participants for the multiple biomarker-risk factor comparisons, we restricted analyses to participants with complete data on all biomarkers. A forest plot shows multivariate-adjusted hazard ratio (squares) and 95% confidence interval (horizontal lines). NT-proBNP indicates N-terminal pro-brain natriuretic peptide, IL-6 interleukin-6, Cyst C cystatin C, ChE cholinesterase, CRP C-reactive protein, Alb albumin, Edu educational status, CVD cardiovascular disease, HBP high blood pressure, HL hyperlipidemia, Major ECG major electrocardiographic abnormality, CV drug cardiovascular medication.CC BY · PubMed Central
Fig. 7 Hazard ratios for cardiovascular and non-cardiovascular mortality in the very old according to circulating biomarkers. Data on cause-specific mortality were available for the very old, aged 85–99 years; 48 died from cardiovascular disease, 41 from cancers, 36 from pneumonia, 5 from advanced dementia, 34 from other causes, and 27 from unknown causes. Those who died from unknown causes were censored in the analysis. Hazard ratios (HRs) and 95% confidence intervals (CIs) for cardiovascular and non-cardiovascular mortality were calculated with the use of univariate and multivariate Cox regression hazard models. Multivariate analyses were adjusted for base model covariates; sex, age, educational status, current smoking, history of cardiovascular disease, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease (stage 3b-5), CRP (≥0.3 mg/dL), major ECG abnormality, cardiovascular medications, and low plasma albumin (<3.5g/dL). Hazard ratios for each biomarker are reported per 1 SD increment in natural log-transformed values (from NT-proBNP to Angptl2, and CRP) or per 1 SD (other variables). For associations of interleukin-6 with mortality, CRP ( ≥0.3 mg/dL) was excluded from the base model because it is a downstream biomarker of the interleukin-6 pathway72. Hyperlipidemia was excluded from the base model for associations of HDL or LDL cholesterol levels with mortality, and diabetes mellitus was excluded for association of hemoglobin A1c with mortality. For associations between EC-SOD and mortality, only individuals with 213RR genotype (non-carrier) in SOD3 (rs1799895) were included in the analysis. aeGFR-cr, CRP and albumin were entered into the base model as continuous variables instead of categorical variables. NT-proBNP N-terminal pro-brain natriuretic peptide, EC-SOD extracellular superoxide dismutase, TNF-alpha tumor necrosis factor-alpha, Angptl2 angiopoietin-like protein 2, HDL high-density lipoprotein, LDL low-density lipoprotein, eGFR-cr estimated glomerular filtration rate based on serum creatinine.
Fig. 7 Hazard ratios for cardiovascular and non-cardiovascular mortality in the very old according to circulating biomarkers. Data on cause-specific mortality were available for the very old, aged 85–99 years; 48 died from cardiovascular disease, 41 from cancers, 36 from pneumonia, 5 from advanced dementia, 34 from other causes, and 27 from unknown causes. Those who died from unknown causes were censored in the analysis. Hazard ratios (HRs) and 95% confidence intervals (CIs) for cardiovascular and non-cardiovascular mortality were calculated with the use of univariate and multivariate Cox regression hazard models. Multivariate analyses were adjusted for base model covariates; sex, age, educational status, current smoking, history of cardiovascular disease, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease (stage 3b-5), CRP (≥0.3 mg/dL), major ECG abnormality, cardiovascular medications, and low plasma albumin (<3.5g/dL). Hazard ratios for each biomarker are reported per 1 SD increment in natural log-transformed values (from NT-proBNP to Angptl2, and CRP) or per 1 SD (other variables). For associations of interleukin-6 with mortality, CRP ( ≥0.3 mg/dL) was excluded from the base model because it is a downstream biomarker of the interleukin-6 pathway72. Hyperlipidemia was excluded from the base model for associations of HDL or LDL cholesterol levels with mortality, and diabetes mellitus was excluded for association of hemoglobin A1c with mortality. For associations between EC-SOD and mortality, only individuals with 213RR genotype (non-carrier) in SOD3 (rs1799895) were included in the analysis. aeGFR-cr, CRP and albumin were entered into the base model as continuous variables instead of categorical variables. NT-proBNP N-terminal pro-brain natriuretic peptide, EC-SOD extracellular superoxide dismutase, TNF-alpha tumor necrosis factor-alpha, Angptl2 angiopoietin-like protein 2, HDL high-density lipoprotein, LDL low-density lipoprotein, eGFR-cr estimated glomerular filtration rate based on serum creatinine.CC BY · PubMed Central
Fig. 8 Prognostic biomarkers in centenarians stratified by the age at death. Spearman’s correlation coefficients of the relationships between prognostic biomarkers identified in Fig. 4 and albumin, and age at enrollment were calculated within decedent centenarian categories: decedent centenarians (died between 100–104 years, blue line), decedent semi-supercentenarians (died between 105–109 years, green line), and decedent supercentenarians (died at ≥110 years, red line). The shaded area represents the 95% confidence interval of the correlation line. All the biomarkers were assessed at the time of enrollment. Population sizes for the five biomarkers differ due to variation in the bio-banking of samples. NT-proBNP indicates N-terminal pro-brain natriuretic peptide. *p < 0.05, **p < 0.01, ***p < 0.001.
Fig. 8 Prognostic biomarkers in centenarians stratified by the age at death. Spearman’s correlation coefficients of the relationships between prognostic biomarkers identified in Fig. 4 and albumin, and age at enrollment were calculated within decedent centenarian categories: decedent centenarians (died between 100–104 years, blue line), decedent semi-supercentenarians (died between 105–109 years, green line), and decedent supercentenarians (died at ≥110 years, red line). The shaded area represents the 95% confidence interval of the correlation line. All the biomarkers were assessed at the time of enrollment. Population sizes for the five biomarkers differ due to variation in the bio-banking of samples. NT-proBNP indicates N-terminal pro-brain natriuretic peptide. *p < 0.05, **p < 0.01, ***p < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 72 references

Cited by

See all 148

Metadata

Authors
Hirata, T., Arai, Y., Yuasa, S., Abe, Y., Takayama, M., Sasaki, T., Kunitomi, A., Inagaki, H., Endo, M., Morinaga, J., Yoshimura, K., Adachi, T., Oike, Y., Takebayashi, T., Okano, H., & Hirose, N.
Affiliations
  • Keio University (JP)
  • Tokyo Metropolitan Institute of Gerontology (JP)
  • University of Occupational and Environmental Health Japan (JP)
  • Kumamoto University (JP)
  • Gifu Pharmaceutical University (JP)
Corresponding author
Arai, Yasumichi
Venue
Nature Communications
Published
2020-07-30
Volume
11
Issue
1
Pages
3820-3820
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3045818979
Cited by
138
References
72
Citations by year
2026: 20 · 2025: 31 · 2024: 28 · 2023: 23 · 2022: 15 · 2021: 19 · 2020: 2
FWCI
4.92
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Keio University
  • Japan Society for the Promotion of Science (15KT0009, 20H03678, 23617024, 21590775)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
supercentenarians, centenarians, oldest old, human longevity, cardiovascular biomarkers, all-cause mortality, NT-proBNP, interleukin-6, cystatin C, cholinesterase, serum albumin, aging
MeSH terms
Aged, 80 and over, Aging, Cardiovascular Diseases, Female, Humans, Longevity, Longitudinal Studies, Male, Peptide Fragments, Predictive Value of Tests, Prospective Studies, Surveys and Questionnaires, Risk Factors, Serum Albumin, Biomarkers, Multivariate Analysis, Survival Analysis, Natriuretic Peptide, Brain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages. https://app.cochat.ai/papers/10.1038/s41467-020-17636-0
The paper
Hirata, T., Arai, Y., Yuasa, S., Abe, Y., Takayama, M., Sasaki, T., Kunitomi, A., Inagaki, H., Endo, M., Morinaga, J., Yoshimura, K., Adachi, T., Oike, Y., Takebayashi, T., Okano, H., & Hirose, N. (2020). Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages. Nature Communications. https://doi.org/10.1038/s41467-020-17636-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.